Clinical Research on the Effect of Aspirin on the Disease Free Survival Rate of Esophageal Carcinoma

Clinical trial NCT03900871 · UNKNOWN

Trial details

NCT number: NCT03900871
Sponsor: Hebei Medical University Fourth Hospital
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Aspirin as an Adjuvant Therapy, to Observe Its Effect on the Disease Free Survival Rate of Patients With Esophageal Squamous Cell Carcinoma

Start date: 2019-04-10
Primary completion: 2020-04-30
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.